MICHELLE EASTON

federal budget issues

federal budget issues

Medicare & Medicaid coverage and reimbursement issues

federal budget issues

Medicare & Medicaid coverage and reimbursement issues

federal budget issues

Medicare & Medicaid coverage and reimbursement issues

federal budget issues

Medicare coverage and reimbursement, Medicaid home and community based care, physician payment proposed rule, care coordination, long-term care, Medicare Advantage, prescription drug access and affordability, Medicaid, alternative payment models

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

orphan drug tax credit

H.R.2617 - Consolidated Appropriations Act, 2023

orphan drug tax credit

H.R.2617 - Consolidated Appropriations Act, 2023

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 patient engagement, alternative payment models, Part B

Medicaid redeterminations, nursing home ownership transparency

Medicaid redeterminations, nursing home ownership transparency, IRA implementation

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 innovation, Duchenne Muscular Dystrophy, platform technologies, non-interference, transparency, value based contracting, gene therapy

H.R.2617 - Consolidated Appropriations Act, 2023

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

Patent reform

orphan drug tax credit

H.R. 5376, the Inflation Reduction Act Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability, transparency, international reference pricing, Medicaid Value Based Payment rule

H.R.2617 - Consolidated Appropriations Act, 2023

Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing, Medicare drug cards, Medicaid Value Based Payment rule, Medicaid waivers

H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug importation, import safety, supply chain integrity, innovation, 304B, transparency, importation, non-interference, user fee reauthorization

health savings accounts, high-deductible health plan telehealth coverage policies

telemedicine, CMMI direct contracting program H.R. 1319, American Rescue Plan of 2021 implementation

H.R. 5376, the Inflation Reduction Act H.R. 5441 and S. 1704, the Telehealth Expansion Act H.R. 2671, the Consolidated Appropriations Act of 2023 telemedicine, liability, pandemic response, testing, vaccines, primary care issues

H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act H.R. 4043, the Ensuring Patient Access to Critical Breakthrough Products Act H.R.2617, Consolidated Appropriations Act, 2023 user fee reauthorization policies

Medicare coverage and reimbursement, Medicare Coverage of Innovative Technology (MCIT) rule

H.R.2617 - Consolidated Appropriations Act, 2023

H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 Medication affordability and access, general diabetes prevention, obesity

issues related to 340B, FDA user fees

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, payment reform, innovation

H.R. 1319, American Rescue Plan of 2021 implementation medicare coverage regulation and reimbursement of imaging services, medicare physician payment, Sunshine Act, equipment maintenance, coding, parallel review, diagnostic endpoints, smart dose implementation, HOPPS, packaging, nuclear medicine, radiopharmaceuticals, E&M codes/budget neutrality

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 510K reform, imaging policy, medical device user fee reauthorization and all related policies, mobile medical apps, device regulation, Innovation, service, radiopharmaceuticals, coverage decisions, cybersecurity

H.R. 5376, the Inflation Reduction Act access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 deficit reduction, appropriations, ARPA-H, reconciliation

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 innovation, non-interference, 340B, Hepatitis C, HPV, Shingles, anti-microbial resistance, transparency, Pandemic All Hazards Preparedness Act reauthorization, drug pricing, anti-microbial resistance, transparency, vaccines

H.R.2617, Consolidated Appropriations Act, 2023 Hospital at Home Legislation

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Provider Relief Fund and institutional special needs plans

H.R. 2471, Consolidated Appropriations Act 2022 H.R. 1319, American Rescue Plan of 2021 implementation institutional special needs plans and Medicare Advantage, network adequacy

competitive bidding, durable medical equipment, Medicare coverage and reimbursement, diagnostics, INR Self-testing, home care, ventilators, sequester relief, E&M codes/budget neutrality, extension of public health emergency

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 coronavirus testing and vaccination, pandemic response

H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 non-interference, dormant therapies, drug shortages, prescription drug access and affordability, transparency, insulin policy, authorized generics, 340B

H.R. 1319, American Rescue Plan of 2021 implementation Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Medicaid Value Based Payment Rule and AMP Cap

medicare coverage and reimbursement, continuous glucose monitors, chronic care, artificial pancreas, diabetes pipeline, insulin

H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 Implementation of the Special Diabetes Program, renewal of the Special Diabetes Program, National Chronic Care Commission, vaccine prioritization, artificial pancreas program, Special Diabetes Program, NIH, innovation in drug development for diabetes, insulin access

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 drug safety, prescription drug abuse, drug pricing

Opioid abuse - general issues related to opioid abuse and access to medication assisted treatment; issues related to ARCOS data and suspicious order record requirements and reporting HR 768 Block, Report, and Suspended Suspicious Shipments Act of 2021 Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA)

S. 3799 PREVENT Pandemics Act S. 1260 United States Innovation and Competition Act H.R. 4521 America COMPETES Act of 2022 S. 4348, FDA Safety and Landmark Advancements Act 2022 H.R.2617, Consolidated Appropriations Act, 2023 General issues related to drug shortages, strategic national stockpile, COVID-19, drug cost oversight, domestic manufacturing of pharmaceutical/medical products, the Public Health Services Act

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 reconciliation, health savings accounts, reinsurance, cost sharing reductions (CSRs), special needs plans, third party payment, risk ratios, individual market reform, market stability, grace periods, special enrollment period, opioids, surprise billing, transparency, all provider claims database, testing, maternal health

medicare, medicaid, rate notice and call letter, medigap, medicaid program operations, medicare operations, MLR, sequestration

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 Pharmaceutical access and affordability, Ryan White, PEPFAR, 340B, HCV Screening, drug pricing and access, HIV, HCV, oncology, coronavirus therapeutics, FDA user fees

Six protected classes, Medicare Part D, HIV, Medicaid, Pharmaceutical access & affordability, Part D benefit redesign, Hepatitis C, HIV, Coronavirus therapeutics, Medicaid Value Based Payment rule

H.R.2617, Consolidated Appropriations Act, 2023 H.R. 5376, the Inflation Reduction Act

H.R.2617, Consolidated Appropriations Act, 2023 telehealth, home health and hospice issues

Home health, hospice care, telemedicine, medicare sequester relief

H.R. 5376, the Inflation Reduction Act prescription drug access and affordability, coding, coverage, value based payments, biosimilars, Part B, Part D, innovation, combination products, 340B, international reference pricing, CMMI

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 drug pricing and access, transparency, covid, 340B, drug safety

H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation

companion diagnostics, payment issues

Pandemic preparedness, FDA policy issues, ARPA-H, life science innovation and competitiveness, preemptive health and medicine, long COVID research, biomanufacturing, next generation vaccines therapeutics

H.R.2617 - Consolidated Appropriations Act, 2023

Medicare and Medicaid Fraud, Advantage, Medicare Part D, Medicaid, Medicaid expansion, Electronic Prescribing, Dual Eligibles, Medigap reform, claims resolution, risk adjustment, Delivery System Reform, Special Needs Plans, Star Ratings, call letter, program integrity, Alzheimer's care, telehealth, chronic care, coding intensity, Medicaid per capita caps, block grant, long term services and supports, value based purchasing, Medicaid MLR, spread pricing, social determinants of health, mental health and substance abuse

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 covid-19 vaccine distribution, pandemic response, stockpile, supply chain

H.R.2617, Consolidated Appropriations Act, 2023

regulatory and payment issues

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug access and affordability, pricing, transparency, user fee reauthorization

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Biosimilars, FDA policies, innovation, 340B, comparative effectiveness research, non-interference, opioids, pandemic preparedness, user fee reauthorization

medicare and medicaid drug reimbursement, medicaid rebate, medicare part D non-interference, biosimilars, 340B, sunshine, discount cards, MedPAC, coding, ASP, Part B, prescription drug access and affordability, transparency, international reference pricing, home infusion, covid therapeutics

S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees

covid therapeutics, pandemic response, regulatory and payment issues

H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act tariff and trade policies, tax reform implementation

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 1319, American Rescue Plan of 2021 implementation Medicare coverage and reimbursement, diagnostics, flow cytometry, Unique Device Identifier, diagnostics, ESRD, Syringes, opioid diversion, artificial intelligence

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Health Savings Accounts/Medical Savings Accounts, Transparency, Health Information Technology, Electronic Prescribing, Insurance Market Reform, Government Plan Option, Uninsured, Employer Based Health System, Health Care Reform, Small Group Market Reform, Exchanges, Health Care Reform Implementation, Medical Loss Ratios, Federal Employees' Health Benefits Program (FEHBP), Delivery System Reform, Risk Corridors and Reinsurance, Affordable Private Health Care, State-Based Regulation, Health Care Quality, Back-end Systems Issues, Telehealth, ACA Implementation, Regional PPOs, Cybersecurity, Co-ops, Special Enrollment Periods, Grace Periods, Risk Mitigation, Market Stabilization, CSRs, risk adjustment, short term limited duration policies, NBPP, surprise billing, spread pricing, Testing, covid-19 response

S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 Drug coverage & reimbursement, vaccination, user fees, no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay

H.R. 5376, the Inflation Reduction Act S. 1260, U.S. Innovation and Competition Act of 2021 H.R. 4521, America COMPETES Act H.R.2617, Consolidated Appropriations Act, 2023 coronavirus- vaccines and therapeutics, PDUFA, antimicrobial resistance, importation, companion diagnostics, innovation, biomarkers, drug importation, 340b, comparative effectiveness, gift disclosure, oncology, personalized medicine, price transparency, adherence

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA, Veterans' Health Care, Medicare physician payment reform, physician workforce, Provider Relief Fund, vaccines and pandemic response, surprise medical billing implementation, MedPAC nomination process

H.R.2617, Consolidated Appropriations Act, 2023 ARPA-H, reconciliation

Medicare physician payment, prescription drug access and affordability, education and outreach, Graduate Medical Education, osteopathic manipulative treatment, opioid alternatives, MedPAC, Resident Physician Shortage

ALS and access to innovation

ALS and access to innovation

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 2461, The Triple A Study Act H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

H.R. 1990 Education and awareness on issues of relevance to individuals with limb loss and limb difference

S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 340B, Biosimilars, Orphan drugs, prescription drug access & reimbursement, FDA issues, transparency

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

Medicare Coverage and Reimbursement Issues, Part B, coding and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B, HOPPS, Home Infusion

H.R.2617, Consolidated Appropriations Act, 2023 NIH funding, appropriations, ARPA-H, reconciliation

S. Con. Res. 14 H.R. 1319, American Rescue Plan of 2021 implementation H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Older Americans Act Implementation, care planning, home and community based care, Independence at Home, CDC Centers of Excellence, BOLD Implementation, HOPE Implementation, RAISE Implementation, NAPA Implementation, Improving HOPE

Medicare coverage and reimbursement, Medicaid home and community based care, anti-psychotics, risk adjustment, Medicare Special Needs Plans, care planning, Independence at Home, physician payment proposed rule, care coordination, long-term care, icd-11, bundling, Medicare Advantage, prescription drug access and affordability, Medicaid, alternative payment models

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

Medicare coverage and reimbursement

H.R.2617, Consolidated Appropriations Act, 2023

H.R.2617, Consolidated Appropriations Act, 2023 ARPA-H, reconciliation

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 opioids, childhood cancer, vaccination, Affordable Care Act, market stabilization, access and coverage, LDT regulation, smoking cessation, Prescription drug pricing and access, Vaping and e-cigarettes

Part B policy and reimbursement, Part D six protected classes

operational and contract issues

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Heath Statistics Act

discount programs, Part B, Part D, Noninterference, CMMI, drug pricing and access, negotiation

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 340B, non-interference, importation, Puerto Rico, transparency, prescription drug pricing and access, beneficiary access

H.R.2617, Consolidated Appropriations Act, 2023

Medicare reimbursement, Medicare competitive bidding for diabetic supplies, Opioids, diagnostics, PAMA, CLIA, Self-testing, Nutrition, Malnutrition and hospital readmissions, Emerging medical device technology, National Coverage Decisions

H.R. 1319, American Rescue Plan of 2021 implementation H.R. 4521, America COMPETES Act S. 1260, United States Competition and Innovation Act H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids, software as a medical device, interoperability, cybersecurity, data privacy, effective pain management, Sunshine, COVID testing, distribution/supply chain

S. 1260, Endless Frontiers Act H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 1260, United States Competition and Innovation Act H.R.2617, Consolidated Appropriations Act, 2023 Immunology, NIH appropriations, Pandemic preparedness, Innovation

CMMI

Home health, hospice care, telemedicine, medicare sequester relief

telehealth, home health and hospice issues

Medicare reimbursement

H.R. 5376, the Build Back Better Act H.R. 2471, Consolidated Appropriations Act 2022

H.R. 5376, the Build Back Better Act

Pandemic preparedness, FDA policy issues, ARPA-H, life science innovation and competitiveness, preemptive health and medicine, long COVID research, biomanufacturing, next generation vaccines therapeutics

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 Medication affordability and access, general diabetes prevention, obesity

H.R. 1577/S. 596 Treat and Reduce Obesity Act of 2021 obesity treatment in COVID-19 relief, Part D redesign

H.R.2617, Consolidated Appropriations Act, 2023

Patent reform, product hopping legislation

H.R. 5376, the Inflation Reduction Act access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 innovation, non-interference, 340B, Hepatitis C, HPV, Shingles, anti-microbial resistance, transparency, Pandemic All Hazards Preparedness Act reauthorization, drug pricing, anti-microbial resistance, transparency, vaccines

ESRD, innovation, Medicare coverage and reimbursement, new tech add-on, kidney care demonstrations, Kidney Rx, home dialysis

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 patient engagement, alternative payment models, Part B

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Testing, private equity/ownership

Bundled Payment for Care Improvement demo, Value based care, CMMI, electronic funds transfer

H.R.2617, Consolidated Appropriations Act, 2023

Medicaid Drug Rebate Program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 innovation, Duchenne Muscular Dystrophy, platform technologies, non-interference, transparency, value based contracting, gene therapy

H.R. 5376, the Inflation Reduction Act Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, Part B, ASP, insulin access, vaccines, flu, prescription drug access and affordability, transparency, international reference pricing, Medicaid Value Based Payment rule

Patent reform

H.R.2617 - Consolidated Appropriations Act, 2023

Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, Alternative Payment Models, Value Based Purchasing, coding, CMMI, Part B, Part D, non-interference, prescription drug access and affordability, transparency, rebates, value based arrangements, benefit redesign, international reference pricing, Medicare drug cards, Medicaid Value Based Payment rule, Medicaid waivers

H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug importation, import safety, supply chain integrity, innovation, 304B, transparency, importation, non-interference, user fee reauthorization

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 Substance abuse, mental health, patient confidentiality, Medicaid Value Based Payment rule and agitation

H.R. 5376, the Inflation Reduction Act Prescription drug access and affordability, 6 protected classes, mental health, chronic kidney disease, dementia, nursing home survey and certification, digital medicine, HIPAA, Part D benefit redesign

health savings accounts, high-deductible health plan telehealth coverage policies

H.R. 5376, the Inflation Reduction Act H.R. 5441 and S. 1704, the Telehealth Expansion Act H.R. 2671, the Consolidated Appropriations Act of 2023 telemedicine, liability, pandemic response, testing, vaccines, primary care issues

telemedicine, CMMI direct contracting program H.R. 1319, American Rescue Plan of 2021 implementation

H.R.2617 - Consolidated Appropriations Act, 2023

Medicare coverage and reimbursement, Medicare Coverage of Innovative Technology (MCIT) rule

H.R. 5376, the Inflation Reduction Act H.R. 6000, the CURES 2.0 Act H.R. 4043, the Ensuring Patient Access to Critical Breakthrough Products Act H.R.2617, Consolidated Appropriations Act, 2023 user fee reauthorization policies

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, payment reform, innovation

H.R.2617, Consolidated Appropriations Act, 2023 Hospital at Home Legislation

Medicaid drug rebate program, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 prescription drug abuse and deterrence, non-interference, supply chain, drug pricing and innovation

H.R. 2471, Consolidated Appropriations Act 2022 H.R. 1319, American Rescue Plan of 2021 implementation institutional special needs plans and Medicare Advantage, network adequacy

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Provider Relief Fund and institutional special needs plans

competitive bidding, durable medical equipment, Medicare coverage and reimbursement, diagnostics, INR Self-testing, home care, ventilators, sequester relief, E&M codes/budget neutrality, extension of public health emergency

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 coronavirus testing and vaccination, pandemic response

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 drug safety, prescription drug abuse, drug pricing

CMMI

medicare, medicaid, rate notice and call letter, medigap, medicaid program operations, medicare operations, MLR, sequestration

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 reconciliation, health savings accounts, reinsurance, cost sharing reductions (CSRs), special needs plans, third party payment, risk ratios, individual market reform, market stability, grace periods, special enrollment period, opioids, surprise billing, transparency, all provider claims database, testing, maternal health

companion diagnostics, payment issues

H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation

H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 non-interference, dormant therapies, drug shortages, prescription drug access and affordability, transparency, insulin policy, authorized generics, 340B

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 1319, American Rescue Plan of 2021 implementation Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Medicaid Value Based Payment Rule and AMP Cap

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 covid-19 vaccine distribution, pandemic response, stockpile, supply chain

H.R.2617, Consolidated Appropriations Act, 2023

S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 prescription drug pricing, prescription drug access and affordability, pricing, transparency, user fees

covid therapeutics, pandemic response, regulatory and payment issues

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 FDA related issues, diagnostics, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation, artificial intelligence, cybersecurity, privacy, medication safety & drug diversion, ESRD, coronavirus response, Operation Warp Speed, COVID-19 testing, user fees

ALS and access to innovation

ALS and access to innovation

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 2461, The Triple A Study Act H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

H.R. 1990 Education and awareness on issues of relevance to individuals with limb loss and limb difference

Medicare physician payment, prescription drug access and affordability, education and outreach, Graduate Medical Education, osteopathic manipulative treatment, opioid alternatives, MedPAC, Resident Physician Shortage

H.R.2617, Consolidated Appropriations Act, 2023 ARPA-H, reconciliation

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Health care access and affordability, pre-exiting conditions, risk adjustment, opioids, workforce reauthorizations, NIH, FDA, Veterans' Health Care, Medicare physician payment reform, physician workforce, Provider Relief Fund, vaccines and pandemic response, surprise medical billing implementation, MedPAC nomination process

H.R. 5376, the Inflation Reduction Act S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 opioids, childhood cancer, vaccination, Affordable Care Act, market stabilization, access and coverage, LDT regulation, smoking cessation, Prescription drug pricing and access, Vaping and e-cigarettes

Part B policy and reimbursement, Part D six protected classes

H.R.2617, Consolidated Appropriations Act, 2023 ARPA-H, reconciliation

H.R.2617 - Consolidated Appropriations Act, 2023

Medicaid access and coverage, Sunshine, medically complex children, access and affordability, transparency, Medicaid Value Based Payment rule H.R. 1319, American Rescue Plan of 2021 implementation

orphan drug tax credit

Medicare coverage and reimbursement, Medicaid home and community based care, anti-psychotics, risk adjustment, Medicare Special Needs Plans, care planning, Independence at Home, physician payment proposed rule, care coordination, long-term care, icd-11, bundling, Medicare Advantage, prescription drug access and affordability, Medicaid, alternative payment models

S. Con. Res. 14 H.R. 1319, American Rescue Plan of 2021 implementation H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Older Americans Act Implementation, care planning, home and community based care, Independence at Home, CDC Centers of Excellence, BOLD Implementation, HOPE Implementation, RAISE Implementation, NAPA Implementation, Improving HOPE

Medicare coverage and reimbursement

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Heath Statistics Act

operational and contract issues

Medicare reimbursement, Medicare competitive bidding for diabetic supplies, Opioids, diagnostics, PAMA, CLIA, Self-testing, Nutrition, Malnutrition and hospital readmissions, Emerging medical device technology, National Coverage Decisions

Issues related to international trade

H.R. 1319, American Rescue Plan of 2021 implementation H.R. 4521, America COMPETES Act S. 1260, United States Competition and Innovation Act H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 medical device user fee reauthorization, diagnostics regulation, in vitro diagnostics, influenza preparedness, opioids, software as a medical device, interoperability, cybersecurity, data privacy, effective pain management, Sunshine, COVID testing, distribution/supply chain

S. 1260, Endless Frontiers Act H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 1260, United States Competition and Innovation Act H.R.2617, Consolidated Appropriations Act, 2023 Immunology, NIH appropriations, Pandemic preparedness, Innovation

H.R. 5376, the Inflation Reduction Act H.R. 4521, America COMPETES Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 510K reform, imaging policy, medical device user fee reauthorization and all related policies, mobile medical apps, device regulation, Innovation, service, radiopharmaceuticals, coverage decisions, cybersecurity

H.R. 1319, American Rescue Plan of 2021 implementation medicare coverage regulation and reimbursement of imaging services, medicare physician payment, Sunshine Act, equipment maintenance, coding, parallel review, diagnostic endpoints, smart dose implementation, HOPPS, packaging, nuclear medicine, radiopharmaceuticals, E&M codes/budget neutrality

Medicare Coverage and Reimbursement Issues, Part B, coding and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B, HOPPS, Home Infusion

product hopping legislation

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act H.R.2617, Consolidated Appropriations Act, 2023 Implementation of the Special Diabetes Program, renewal of the Special Diabetes Program, National Chronic Care Commission, vaccine prioritization, artificial pancreas program, Special Diabetes Program, NIH, innovation in drug development for diabetes, insulin access

medicare coverage and reimbursement, continuous glucose monitors, chronic care, artificial pancreas, diabetes pipeline, insulin

H.R.2617 - Consolidated Appropriations Act, 2023

H.R. 5376, the Inflation Reduction Act H.R.2617, Consolidated Appropriations Act, 2023 Health Savings Accounts/Medical Savings Accounts, Transparency, Interoperability, Health Information Technology, Electronic Prescribing, Insurance Market Reform, Uninsured, Employer Based Health System, Exchanges, Risk Corridors and Reinsurance, Federal employees and regional PPOs, Cybersecurity, telehealth, Co-ops, special enrollment periods, Risk Mitigation, mental health, opioid abuse, market stabilization, out of network billing, risk adjustment, value based purchasing, NBPP, surprise billing, prior authorization, cybersecurity, privacy, spread pricing, Testing, McCarran Ferguson, maternal health